SPECIAL NOTICE
65 -- Notice of Intent to Sole Source � Therakos, Inc.
- Notice Date
- 7/8/2024 12:45:22 PM
- Notice Type
- Special Notice
- NAICS
- 339112
— Surgical and Medical Instrument Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 24-008555
- Response Due
- 7/23/2024 6:00:00 AM
- Archive Date
- 08/07/2024
- Description
- This urgent acquisition is for Uvadex (methoxsalen) Sterile Solution for the National Institutes of Health (NIH) Clinical Center (CC) Central Pharmacy. ������������ Product Service Code: 6515 � Surgical and Medical Equipment and Supplies ������������ NAICS Code: 339112 � Surgical and Medical Instrument Manufacturing ������������ Place of Performance: Bethesda, MD 20892 USA POTS: 24-008555 Description: This is a notice of intent, not a request for a quotation. �A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Therakos, Inc., located at 675 James S McDonnell Blvd, Hazelwood, MO 63042, on a firm fixed price sole source award basis to provide Uvadex to the National Institutes of Health. Below is a description of the item(s): Description: Uvadex (Methoxsalen) 20 mcg/mL; Sterile Solution Catalog #: 21612 Units: Carton Qty: 2 The proposed vendor, Therakos, Inc, is able to provide this urgent requirement for pharmaceutical supplies within the required time to the NIH CC Central Pharmacy. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.� Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 23, 2024 at 9am EST.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/2de0318235a644c4b7bf44ae6bd49239/view)
- Place of Performance
- Address: Bethesda, MD, USA
- Country: USA
- Country: USA
- Record
- SN07119465-F 20240710/240708230109 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |